Compliance and Stewardship: Waste Reduction and Cost Savings

Opinion
Video

Health care providers discuss how prefilled syringes reduce diversion risks, enhance waste management, and offer cost-effective solutions, ensuring compliance with regulations.

This is a video synopsis/summary of a Practice Pearls featuring Ryan Haumschild, PharmD, MS, MBA, CPEL; Megan Mitchell, PharmD, MS; Stephanie Abel, PharmD, BCPS; and Jennifer Grate, CPhT.

Haumschild leads a comprehensive discussion on prefilled syringes, waste management, and diversion risk with Grate. Haumschild emphasizes the importance of evaluating care locations and total cost considerations beyond product costs. Grate discusses diversion risks, highlighting vial-related challenges, such as overfill diversion opportunities and concealment ease. She contrasts this with prefilled syringes, emphasizing reduced waste and syringe visibility, minimizing diversion risks. As the conversation shifts to waste management, Grate outlines best practices for prefilled syringe disposal, emphasizing irretrievability and proper pharmaceutical destruction. She recommends using designated containers for controlled substances, debunking the use of sharps containers. Haumschild acknowledges the impact on waste reduction and the importance of adhering to guidelines. Grate emphasizes the safety and effectiveness of utilizing sharps containers for syringe disposal. The discussion concludes with insights into reducing waste frequency and implementing efficient waste disposal practices.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.

Related Videos
Video 4 - "Applying NCCN Guidelines in the Treatment of mBC"
Video 6 - "Impact of Social Determinants of Health on Respiratory Syncytial Virus (RSV)"
Video 5 - "Addressing Respiratory Vaccine Fatigue"
Video 1 - "Preventing RSV in Adults: Current Vaccination Options"
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
Video 15 - "Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM  "
Video 12 - "Pharmacist Role in Addressing Operational Challenges of  Bispecifics in MM"
Video 12 - "Pharmacist Role in Addressing Operational Challenges of  Bispecifics in MM"
Related Content
© 2024 MJH Life Sciences

All rights reserved.